617 related articles for article (PubMed ID: 17895777)
1. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma.
Cirak B; Horská A; Barker PB; Burger PC; Carson BS; Avellino AM
Childs Nerv Syst; 2005 May; 21(5):404-9. PubMed ID: 15372294
[TBL] [Abstract][Full Text] [Related]
4. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
5. Imaging characteristics of pilomyxoid astrocytomas in comparison with pilocytic astrocytomas.
Lee IH; Kim JH; Suh YL; Eo H; Shin HJ; Yoo SY; Lee KS
Eur J Radiol; 2011 Aug; 79(2):311-6. PubMed ID: 20619565
[TBL] [Abstract][Full Text] [Related]
6. Dysembryoplastic neuroepithelial tumors: magnetic resonance imaging and magnetic resonance spectroscopy evaluation.
Yu AH; Chen L; Li YJ; Zhang GJ; Li KC; Wang YP
Chin Med J (Engl); 2009 Oct; 122(20):2433-7. PubMed ID: 20079155
[TBL] [Abstract][Full Text] [Related]
7. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas.
Porto L; Kieslich M; Franz K; Lehrbecher T; Pilatus U; Hattingen E
Brain Tumor Pathol; 2010 Oct; 27(2):65-70. PubMed ID: 21046307
[TBL] [Abstract][Full Text] [Related]
9. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
Luan W; Zhang J
Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
[TBL] [Abstract][Full Text] [Related]
10. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
[TBL] [Abstract][Full Text] [Related]
11. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
Johnson MW; Eberhart CG; Perry A; Tihan T; Cohen KJ; Rosenblum MK; Rais-Bahrami S; Goldthwaite P; Burger PC
Am J Surg Pathol; 2010 Dec; 34(12):1783-91. PubMed ID: 21107083
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
15. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
16. Pilomyxoid astrocytoma: diagnosis, prognosis, and management.
Komotar RJ; Mocco J; Jones JE; Zacharia BE; Tihan T; Feldstein NA; Anderson RC
Neurosurg Focus; 2005 Jun; 18(6A):E7. PubMed ID: 16048293
[TBL] [Abstract][Full Text] [Related]
17. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
Ng WH; Lim T
J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
[TBL] [Abstract][Full Text] [Related]
19. Pilomyxoid astrocytoma: neuroimaging with clinicopathologic correlates in 4 cases followed over time.
Komakula ST; Fenton LZ; Kleinschmidt-DeMasters BK; Foreman NK
J Pediatr Hematol Oncol; 2007 Jul; 29(7):465-70. PubMed ID: 17609624
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]